CUL4B and osteosarcoma: We also observed a significant decrease in CDK2 levels after down-regulation of CUL4B, DDB1 or DCAF11 in osteosarcoma cells (Fig. 6A), which raised the question of whether DCAF11 is responsible for the degradation of CDK2.